Bosutinib: Don't Believe the Label!
Linkedin

Bosutinib: Don't Believe the Label!

Oxford : United Kingdom | May 14, 2012 at 11:12 AM PDT
Source: In the Pipeline
XX XX
Views: Pending
 
Now here's a worrisome thought, if you're doing kinase research. A tyrosine kinase inhibitor in the clinic against Bcr-Abl, bosutinib (SKI-606), is also being used as a research tool in a number of academic groups. But they're probably not using what they think they're using. FULL ARTICLE AT In the Pipeline
 
  • Clear
  • Share:
  • Share
  • Clear
  • Clear
  • Clear
  • Clear
 
 
Advertisement
 
Advertisement
 

More From Allvoices

 
Tap_logo_330_110_event
 


Use of this site is governed by our Terms of Use Agreement and Privacy Policy.

© Allvoices, Inc 2008-2013. All rights reserved.